Information for "Protecting Results of Irbesartan the Angiotensin Receptor Blocker together with PPAR Agonistic Task towards Estradiol BenzoateInduced Endometrial Hyperplasia and also Atypia throughout Woman Subjects through Modulation associated with TNFSurvivin Walkway"
From EECH Central
Basic information
| Display title | Protecting Results of Irbesartan the Angiotensin Receptor Blocker together with PPAR Agonistic Task towards Estradiol BenzoateInduced Endometrial Hyperplasia and also Atypia throughout Woman Subjects through Modulation associated with TNFSurvivin Walkway |
| Default sort key | Protecting Results of Irbesartan the Angiotensin Receptor Blocker together with PPAR Agonistic Task towards Estradiol BenzoateInduced Endometrial Hyperplasia and also Atypia throughout Woman Subjects through Modulation associated with TNFSurvivin Walkway |
| Page length (in bytes) | 3,534 |
| Page ID | 1431199 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Hubcapcloudy2 (Talk | contribs) |
| Date of page creation | 14:03, 2 May 2024 |
| Latest editor | Hubcapcloudy2 (Talk | contribs) |
| Date of latest edit | 14:03, 2 May 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
